DNTH
Price
$88.33
Change
+$0.01 (+0.01%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
4.91B
34 days until earnings call
Intraday BUY SELL Signals
IMTX
Price
$7.59
Change
-$0.85 (-10.07%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
1.29B
46 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DNTH vs IMTX

DNTH vs IMTX Comparison Chart in %
View a ticker or compare two or three
VS
DNTH vs. IMTX commentary
Oct 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNTH is a Hold and IMTX is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
DNTH vs IMTX: Fundamental Ratings
DNTH
IMTX
OUTLOOK RATING
1..100
5722
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
78
Overvalued
PROFIT vs RISK RATING
1..100
10100
SMR RATING
1..100
9698
PRICE GROWTH RATING
1..100
4361
P/E GROWTH RATING
1..100
5251
SEASONALITY SCORE
1..100
5065

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMTX's Valuation (78) in the null industry is in the same range as DNTH (80). This means that IMTX’s stock grew similarly to DNTH’s over the last 12 months.

DNTH's Profit vs Risk Rating (10) in the null industry is significantly better than the same rating for IMTX (100). This means that DNTH’s stock grew significantly faster than IMTX’s over the last 12 months.

DNTH's SMR Rating (96) in the null industry is in the same range as IMTX (98). This means that DNTH’s stock grew similarly to IMTX’s over the last 12 months.

DNTH's Price Growth Rating (43) in the null industry is in the same range as IMTX (61). This means that DNTH’s stock grew similarly to IMTX’s over the last 12 months.

IMTX's P/E Growth Rating (51) in the null industry is in the same range as DNTH (52). This means that IMTX’s stock grew similarly to DNTH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DNTHIMTX
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
69%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 3 days ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 9 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
70%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
COMPARISON
Comparison
Oct 02, 2026
Stock price -- (DNTH: $88.32 vs. IMTX: $8.44)
Brand notoriety: DNTH and IMTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNTH: 109% vs. IMTX: 94%
Market capitalization -- DNTH: $4.91B vs. IMTX: $1.29B
DNTH [@Biotechnology] is valued at $4.91B. IMTX’s [@Biotechnology] market capitalization is $1.29B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNTH’s FA Score shows that 1 FA rating(s) are green while IMTX’s FA Score has 0 green FA rating(s).

  • DNTH’s FA Score: 1 green, 4 red.
  • IMTX’s FA Score: 0 green, 5 red.
According to our system of comparison, DNTH is a better buy in the long-term than IMTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNTH’s TA Score shows that 4 TA indicator(s) are bullish while IMTX’s TA Score has 3 bullish TA indicator(s).

  • DNTH’s TA Score: 4 bullish, 5 bearish.
  • IMTX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, DNTH is a better buy in the short-term than IMTX.

Price Growth

DNTH (@Biotechnology) experienced а -2.63% price change this week, while IMTX (@Biotechnology) price change was +1.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.63%. For the same industry, the average monthly price growth was -14.35%, and the average quarterly price growth was -1.64%.

Reported Earning Dates

DNTH is expected to report earnings on Nov 05, 2026.

IMTX is expected to report earnings on Nov 17, 2026.

Industries' Descriptions

@Biotechnology (-3.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
DNTH
Daily Signal:
Gain/Loss:
IMTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MXC9.970.13
+1.32%
Mexco Energy Corp
EXP173.072.05
+1.20%
Eagle Materials
IMMR7.310.08
+1.11%
Immersion Corp
GD332.720.89
+0.27%
General Dynamics Corp
BRAI5.31-0.09
-1.67%
Braiin Limited

DNTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNTH has been loosely correlated with EDIT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if DNTH jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNTH
1D Price
Change %
DNTH100%
+0.31%
EDIT - DNTH
46%
Loosely correlated
-1.95%
XENE - DNTH
44%
Loosely correlated
+4.68%
IMTX - DNTH
42%
Loosely correlated
-3.87%
ORKA - DNTH
42%
Loosely correlated
+0.16%
REPL - DNTH
41%
Loosely correlated
+1.59%
More

IMTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMTX has been loosely correlated with SLDB. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if IMTX jumps, then SLDB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMTX
1D Price
Change %
IMTX100%
-3.87%
SLDB - IMTX
52%
Loosely correlated
-3.46%
VIR - IMTX
48%
Loosely correlated
+0.98%
ABEO - IMTX
47%
Loosely correlated
-4.57%
EDIT - IMTX
47%
Loosely correlated
-1.95%
RXRX - IMTX
45%
Loosely correlated
-1.45%
More